Self Paced

Antiviral Drug Development: Innovations and Applications

Shaping the Future of Public Health: Innovate in Antiviral Drug Development

star_full star_full star_full star_full star_full

MODE
Online/ e-LMS
TYPE
Mentor Based
LEVEL
Moderate
DURATION
3 Months

About

“Antiviral Drug Development: Innovations and Applications” is an intensive program designed to introduce participants to the dynamic field of antiviral research and pharmaceutical development. This course will cover fundamental virology, the mechanisms of viral entry and replication, and the current landscape of antiviral therapies including small molecule drugs, vaccines, and novel therapeutic strategies such as RNA interference and CRISPR-based treatments.

Aim

This program aims to equip participants with cutting-edge knowledge and practical skills necessary for the development and application of antiviral drugs. It focuses on the latest research, innovation in drug design, and the application of these drugs in managing and treating viral infections effectively.

Program Objectives

  • Explore the diverse range of viruses and their impact on human health.
  • Gain insights into the drug discovery process for antiviral therapies.
  • Understand the mechanisms of action of different antiviral drugs.
  • Analyze the challenges associated with antiviral drug resistance.
  • Discuss the latest innovations in antiviral drug development, including gene editing and RNA interference

Program Structure

Module 1: Foundations and Innovations
Week 1: Introduction to Viral Diseases

  • Introduction to basic virology, including virus structure and function.
  • Overview of viral pathogenesis and its impact on human health.
  • Readings on the historical impact of viral outbreaks globally.

Week 2: Target Identification in Antiviral Research

  • Exploration of methodologies for identifying viral targets essential for replication and infection.
  • Overview of the role of target identification in antiviral drug development.
  • Interactive simulations that demonstrate the target identification process.

Week 3: Antiviral Drug Design Principles

  • Principles of drug design and the application of AI and machine learning in developing antivirals.
  • Case studies of successful antiviral drugs and their mechanisms of action.
  • Overview of molecular modeling and drug docking techniques.

Week 4: Screening and Optimization

  • Introduction to high-throughput screening methods used in antiviral research.
  • Techniques for optimizing drug candidates through iterative testing.
  • Virtual lab experiences on different screening methodologies and hit optimization.

Module 2: Development and Testing
Week 5: Preclinical Development

  • Key stages in antiviral drug development before clinical trials begin.
  • Importance of pharmacokinetics and pharmacodynamics in preclinical testing.
  • Interactive timeline activities outlining the drug development process.

Week 6: Clinical Trial Design for Antiviral Drugs

  • Elements of designing effective and ethical clinical trials for antiviral therapies.
  • Simulation of clinical trial phases and design considerations.
  • Discussion on adaptive trial designs and their benefits in antiviral research.

Week 7: Ethical Considerations in Drug Development

  • Ethical issues in the development and testing of antiviral drugs.
  • Scenario analysis and discussion forums on ethical dilemmas in clinical research.
  • Overview of informed consent and its importance in clinical trials.

Week 8: Regulatory Affairs in Antiviral Drug Approval

  • Understanding the regulatory pathway for antiviral drug approval.
  • Mock exercises on preparing submissions for regulatory review.
  • Study of global differences in drug approval processes and how they impact drug launch.

Month 3: Advanced Topics and Future Directions
Week 9: Resistance and Challenges

  • Mechanisms behind antiviral resistance and the implications for treatment strategies.
  • Research tasks focused on current resistance scenarios and potential solutions.
  • Discussion of surveillance and monitoring strategies for resistance management.

Week 10: Vaccines vs. Therapeutics

  • Comparative analysis of vaccines and therapeutics in managing viral diseases.
  • Group projects to develop a proposal focusing on either vaccine or therapeutic development.
  • Strategic integration of vaccines and therapeutics in public health.

Week 11: Emerging Technologies in Antiviral Therapies

  • Overview of cutting-edge technologies such as CRISPR and nanoparticle delivery systems in antiviral therapy.
  • Future scenario planning exercises for the next generation of antiviral treatments.
  • Discussion of the potential of these technologies to revolutionize antiviral therapies.

Week 12: Capstone Project

  • Guidelines for developing innovative antiviral treatments as a capstone project.
  • Resources and support provided for project development.
  • Presentation and critique sessions to evaluate the effectiveness and innovation of the projects.

Participant’s Eligibility

  • Undergraduate degree in Pharmacy, Biotechnology, or related fields.
  • Professionals in pharmaceutical, biotechnology, and healthcare sectors.
  • Individuals with a strong foundation in molecular biology and a passion for medical innovation.

Program Outcomes

  • Acquire the knowledge and skills to critically evaluate current and future antiviral drugs.
  • Develop an understanding of the regulatory processes involved in bringing new antiviral therapies to market.
  • Gain insights into potential career paths within the antiviral drug development industry.
  • Stay informed about the latest advancements in antiviral research.


Fee Structure

Standard Fee:           INR 49,998           USD 1,300

Discounted Fee:       INR 24999             USD 650

Batches

Spring
Summer

Autumn
Winter

Certificate

Program Assessment

Certification to this program will be based on the evaluation of following assignment (s)/ examinations:

Exam Weightage
Mid Term Assignments 20 %
Final Online Exam 30 %
Project Report Submission (Includes Mandatory Paper Publication) 50 %

To study the printed/online course material, submit and clear, the mid term assignments, project work/research study (in completion of project work/research study, a final report must be submitted) and the online examination, you are allotted a 1-month period. You will be awarded a certificate, only after successful completion/ and clearance of all the aforesaid assignment(s) and examinations.

Program Deliverables

  • Access to e-LMS
  • Real Time Project for Dissertation
  • Project Guidance
  • Paper Publication Opportunity
  • Self Assessment
  • Final Examination
  • e-Certification
  • e-Marksheet

Future Career Prospects

  • Antiviral Research Scientist
  • Pharmaceutical Developer
  • Clinical Trial Specialist
  • Regulatory Affairs Manager
  • Public Health Advisor
  • Biotechnology Consultant

Enter the Hall of Fame!

Take your research to the next level!

Publication Opportunity
Potentially earn a place in our coveted Hall of Fame.

Centre of Excellence
Join the esteemed Centre of Excellence.

Networking and Learning
Network with industry leaders, access ongoing learning opportunities.

Hall of Fame
Get your groundbreaking work considered for publication in a prestigious Open Access Journal (worth ₹20,000/USD 1,000).

Achieve excellence and solidify your reputation among the elite!


×

Still have any Query?